Search Results 1311-1320 of 35309 for prostate cancer
... prostate cancer (mCRPC). There will be three cohorts in this study with 70 participants enrolled in each cohort: Cohort A will receive pembrolizumab + ...
Proton therapy for prostate cancer, Radiation therapy for prostate cancer, Prostate cancer, Breast cancer, Bladder cancer, Cervical cancer, Endometrial ...
... Prostate biopsy, Prostate artery embolization, R...adiation therapy for prostate cancer, Lymphangiogram, Tumor biopsy, Prostate ablation, Thoracic duct ...
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA. J Immunother ...
Prostate cancer, Bladder cancer, Kidney cancer, Testicular cancer, Ureteral cancer, Metastatic prostate cancer, Metasta...tic castration-resistant prostate ...
... prostate cancer: A National Cancer Database Analysis. Prostate Cancer Prostatic Dis. 2020 Jun; 23 (2):349-355 Epub 2019 Nov 28. View PubMed; Stross WC ...
Prostate cancer. Dr. Larson examines how genetics contribute to the risk of prostate cancer. He is specifically interested in how identified genetic risk ...
Chemotherapy, Biological therapy for cancer, Chemotherapy for prostate cancer, Prostate cancer, Bladder cancer, Kidney ...cancer, Melanoma, Testicular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!